Allogeneic stem cell transplantation as a curative option in relapse/refractory diffuse large B cell lymphoma: Spanish multicenter GETH/GELTAMO study
Leyre Bento, Antonio Gutiérrez, Silvana Novelli, Juan Montoro, José Luís Piñana, Lucía López‐Corral, Mónica Cabrero, Alejandro Martı́n, Gonzalo Gutiérrez, Marcela Ortiz-Moscovich, Mariana Bastos‐Oreiro, Nieves Dorado, Ariadna Pérez, Rafael Hernani, Christelle Ferrá, Rocío Parody, Irene García‐Cadenas, Pilar Herrera, Guillermo Rodríguez‐Domínguez, Nancy Rodríguez, Carmen Martín, Lucrecia Yáñez, Joud Zanabili, Rosario Varela, Oriana López‐Godino, Inmaculada Heras, Ignacio Español, Carmen Martı́nez, Josè Antonio Pérez-Simón, Carlos Solano, Anna Sureda, Jordi Sierra, Antònia Sampol, Dolores Caballero, on behalf of the Grupo Español de Trasplante Hematopoyético (GETH) and Grupo Español de Linfoma y Trasplante Autólogo (GELTAMO)
Topics & Concepts
MedicineInternal medicineCumulative incidenceTransplantationRefractory (planetary science)GastroenterologyHematopoietic stem cell transplantationLymphomaIncidence (geometry)Graft-versus-host diseaseSurgeryChemotherapyAstrobiologyOpticsPhysicsCAR-T cell therapy researchLymphoma Diagnosis and TreatmentHematopoietic Stem Cell Transplantation